NP_001244303.1
[Other Products]
NCBI GenBank Nucleotide #
|
[Other Products]
UniProt Primary Accession #
|
[Other Products]
UniProt Secondary Accession #
UniProt Related Accession #
Molecular Weight
69,249 Da
NCBI Official Full Name
lamin isoform D
NCBI Official Synonym Full Names
lamin A/C
NCBI Official Synonym Symbols
FPL; IDC; LFP; CDDC; EMD2; FPLD; HGPS; LDP1; LMN1; LMNC; MADA; PRO1; CDCD1; CMD1A; FPLD2; LMNL1; CMT2B1; LGMD1B [Similar Products]
NCBI Protein Information
lamin
UniProt Protein Name
Prelamin-A/C
UniProt Synonym Protein Names
Lamin-A/CAlternative name(s):70 kDa lamin; Renal carcinoma antigen NY-REN-32
UniProt Synonym Gene Names
NCBI Summary for LMNA
The nuclear lamina consists of a two-dimensional matrix of proteins located next to the inner nuclear membrane. The lamin family of proteins make up the matrix and are highly conserved in evolution. During mitosis, the lamina matrix is reversibly disassembled as the lamin proteins are phosphorylated. Lamin proteins are thought to be involved in nuclear stability, chromatin structure and gene expression. Vertebrate lamins consist of two types, A and B. Alternative splicing results in multiple transcript variants. Mutations in this gene lead to several diseases: Emery-Dreifuss muscular dystrophy, familial partial lipodystrophy, limb girdle muscular dystrophy, dilated cardiomyopathy, Charcot-Marie-Tooth disease, and Hutchinson-Gilford progeria syndrome. [provided by RefSeq, Apr 2012]
UniProt Comments for LMNA
lamin A/C: nuclear lamins are intermediate filament proteins that constitute the lattice-like matrix at the inner face of the nuclear membrane that underlies the nuclear envelop. The lamins, highly conserved throughout evolution, are encoded by three genes in the human: LMNA, LMNB1, and LMNB2. The A-type lamins (lamin A/C) are developmentally regulated and are generally expressed in differentiated cells. The anchoring of chromatin to the nuclear lamina is involved in the control of gene expression and in DNA replication and repair. During mitosis, the nuclear lamina is reversibly disassembled as the lamin proteins are phosphorylated. Cleaved by caspase-6 during apoptosis into a 40-45 kDa and a28 kDa fragment.
Protein type: Cytoskeletal
Chromosomal Location of Human Ortholog: 1q22
Cellular Component: cytosol; extracellular matrix; lamin filament; nuclear envelope; nuclear membrane; nuclear speck; nucleoplasm; nucleus
Molecular Function: protein binding; structural molecule activity
Biological Process: cellular response to hypoxia; establishment or maintenance of microtubule cytoskeleton polarity; IRE1-mediated unfolded protein response; mitotic nuclear envelope disassembly; mitotic nuclear envelope reassembly; negative regulation of cell proliferation; negative regulation of extrinsic apoptotic signaling pathway; negative regulation of mesenchymal cell proliferation; negative regulation of release of cytochrome c from mitochondria; positive regulation of cell aging; protein localization to nucleus; regulation of cell migration; regulation of protein localization to nucleus; sterol regulatory element binding protein import into nucleus; ventricular cardiac muscle cell development
Disease: Cardiomyopathy, Dilated, 1a; Cardiomyopathy, Dilated, With Hypergonadotropic Hypogonadism; Charcot-marie-tooth Disease, Axonal, Type 2b1; Emery-dreifuss Muscular Dystrophy 2, Autosomal Dominant; Emery-dreifuss Muscular Dystrophy 3, Autosomal Recessive; Heart-hand Syndrome, Slovenian Type; Hutchinson-gilford Progeria Syndrome; Lipodystrophy, Familial Partial, Type 2; Mandibuloacral Dysplasia With Type A Lipodystrophy; Muscular Dystrophy, Congenital, Lmna-related; Muscular Dystrophy, Limb-girdle, Type 1b; Restrictive Dermopathy, Lethal
Research Articles on LMNA
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice. It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Products associated with anti-LMNA antibody
Pathways associated with anti-LMNA antibody
Diseases associated with anti-LMNA antibody
Disease Name |
Pubmed Publications |
Cardiovascular Diseases Antibodies |
>229 publications with LMNA and Cardiovascular Diseases |
Progeria Antibodies |
>210 publications with LMNA and Progeria |
Hutchinson Gilford progeria syndrome Antibodies |
>210 publications with LMNA and Hutchinson Gilford progeria syndrome |
Heart Diseases Antibodies |
>203 publications with LMNA and Heart Diseases |
Cardiomyopathy, Dilated Antibodies |
>177 publications with LMNA and Cardiomyopathy, Dilated |
Muscular Dystrophy, Emery-Dreifuss Antibodies |
>131 publications with LMNA and Muscular Dystrophy, Emery-Dreifuss |
Lipodystrophy, Familial Partial Antibodies |
>120 publications with LMNA and Lipodystrophy, Familial Partial |
LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 Antibodies |
>120 publications with LMNA and LIPODYSTROPHY, FAMILIAL PARTIAL, TYPE 2 |
Death, Sudden, Cardiac Antibodies |
>43 publications with LMNA and Death, Sudden, Cardiac |
Muscular Dystrophies, Limb-Girdle Antibodies |
>35 publications with LMNA and Muscular Dystrophies, Limb-Girdle |
Organs/Tissues associated with anti-LMNA antibody
|